CUSIP 29970R204
EVAXION BIOTECH A/S
13 institutions · $6.1M total · 1,495,809 shares
| # | Manager | Shares | Value | % of Total | Period |
|---|---|---|---|---|---|
| 1 | Merck & Co., Inc. | 1,214,126 | $5.8M | 81.16% | 2025-12-31 |
| 2 | ARMISTICE CAPITAL, LLC | 150,462 | $127.2K | 10.05% | 2024-12-31 |
| 3 | CITADEL ADVISORS LLC | 14,825 | $46.1K | 0.99% | 2024-09-30 |
| 4 | Invst, LLC | 50,400 | $42.6K | 3.36% | 2024-12-31 |
| 5 | Catalina Capital Group, LLC | 34,864 | $29.5K | 2.33% | 2024-12-31 |
| 6 | MILLENNIUM MANAGEMENT LLC | 22,541 | $18.8K | 1.50% | 2024-12-31 |
| 7 | JPMORGAN CHASE & CO | 2,180 | $6.2K | 0.14% | 2024-12-31 |
| 8 | BlackRock, Inc. | 1,512 | $4.7K | 0.10% | 2024-09-30 |
| 9 | Beacon Capital Management, LLC | 4,863 | $4.1K | 0.32% | 2024-12-31 |
| 10 | Tower Research Capital LLC (TRC) | 30 | $96 | 0.00% | 2024-03-31 |
| 11 | RHUMBLINE ADVISERS | 2 | $7 | 0.00% | 2025-09-30 |
| 12 | SouthState Corp | 4 | $3 | 0.00% | 2024-12-31 |
| 13 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 2024-12-31 |